Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Clinical trial NCT05961839 · TERMINATED

Trial details

NCT number: NCT05961839
Sponsor: Schrödinger, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia High-Risk and Very High-Risk Myelodysplastic Syndromes

Start date: 2023-09-27
Primary completion: 2025-08-14
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.